menu
    • menu

    Company profile for Longeveron

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 ...
    Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 million Americans over the age of 60.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LongeveronUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1951 NW 7TH AVENUE SUITE 520 MIAMI, FL 33136
    Telephone
    Telephone
    305.909.0840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.longeveron.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/longeveron-llc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Longeveron Cso And Cmo To Speak At Global (CVCT) Forum
    Longeveron Cso And Cmo To Speak At Global (CVCT) Forum

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198986/0/en/Longeveron-Chief-Science-Officer-and-Chief-Medical-Officer-Selected-as-Speakers-at-the-Global-CardioVascular-Clinical-Trialists-CVCT-Forum.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Longeveron Presents New MRI Biomarker Data On Neuroinflammation
    Longeveron Presents New MRI Biomarker Data On Neuroinflammation

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197308/0/en/Longeveron-New-MRI-Biomarker-Data-Linking-Neuroinflammation-to-Clinical-Outcomes-in-Patients-with-Mild-Alzheimer-s-Disease-Presented-at-the-Clinical-Trials-on-Alzheimer-s-Disease-C.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Longeveron's Laromestrocel Selected for CTAD 2025
    Longeveron's Laromestrocel Selected for CTAD 2025

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191065/0/en/Longeveron-Laromestrocel-Data-in-Alzheimer-s-Disease-Selected-for-Poster-Presentation-at-the-Clinical-Trials-on-Alzheimer-s-Disease-Conference-CTAD-2025.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Longeveron Secures U.S. Patent For Treating Aging-Related Frailty
    Longeveron Secures U.S. Patent For Treating Aging-Related Frailty

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186382/0/en/Longeveron-Granted-U-S-Patent-for-Method-of-Treating-Aging-related-Frailty-in-Patients-with-Inflammaging-Using-its-Proprietary-Stem-Cell-Therapy.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Longeveron Unveils Q3 2025 Financials & Business Update
    Longeveron Unveils Q3 2025 Financials & Business Update

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180876/0/en/Longeveron-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Longeveron to Host Call on November 4, 2025 for Q3 Result
    Longeveron to Host Call on November 4, 2025 for Q3 Result

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175547/0/en/Longeveron-to-Report-Third-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-November-4-2025.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search